Kimia Biosciences Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Kimia Biosciences Ltd. on BSE

Search Inside the pdf :

Kimia Biosciences Ltd.

21 Aug 2025

38.45

2.86%

Company Update

Kimia Biosciences Ltd - 530313 - Revised Outcome Of Board Meeting Dated 14.08.2025

BSE India

It is hereby submitted that revised outcome of Board Meeting is being filed here with reference to the previously filed outcome of Board Meeting vide Acknowledgement Number 10616056 for the Board Meeting held on 14.08.2025 as the meeting closure time was wrongly mentioned as 2:30 P.M. instead of 1:30 P.M.

pdf

Kimia Biosciences Ltd.

16 Aug 2025

38.45

2.86%

Company Update

Kimia Biosciences Ltd - 530313 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation, 2015, please find the Newspaper publications of Unaudited Standalone Financial Results of the Company for the quarter ended June 30, 2025 in the following newspapers: 1. Financial Express (New Delhi Edition) - English 2. Jansatta (New Delhi Edition) - Hindi The publications were made in the above newspapers dated August 15, 2025

pdf

Kimia Biosciences Ltd.

14 Aug 2025

38.45

2.86%

Company Update

Kimia Biosciences Ltd - 530313 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Appointment of CFO

pdf

Kimia Biosciences Ltd.

14 Aug 2025

38.45

2.86%

Board Meeting

Kimia Biosciences Ltd - 530313 - Board Meeting Outcome for Board Meeting Outcome For Board Meeting …

BSE India

Outcome of Board Meeting under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015.

pdf

Kimia Biosciences Ltd.

14 Aug 2025

38.45

2.86%

Result

Kimia Biosciences Ltd - 530313 - Financial Results For The Quarter Ended June 30, 2025

BSE India

Financial Results for the quarter ended June 30, 2025

pdf

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	24.43	38.69	22.48	-36.9%	8.7%
Operating Profit Qtr	2.53	8.18	3.70	-69.1%	-31.6%
Net Profit Qtr	0.60	1.99	1.44	-69.8%	-58.3%
Earning Per Share Adjusted latest Qtr	0.13	0.42	0.30	-69.0%	-56.7%

* Standalone data

Detailed Results

Kimia Biosciences Ltd.

08 Aug 2025

38.45

2.86%

Board Meeting

Kimia Biosciences Ltd - 530313 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation …

BSE India

Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve 1. Unaudited Standalone Financial Results of the Company for the quarter ended June 30, 2025; 2. Warning Letter dated July 25, 2025 received from BSE Limited ('BSE'); 3. Unsecured loan of amount 2 Crores with an interest rate of 8% per annum thereof; and 4. Appointment of Mr. Pradip Kumar Sharma as Chief Financial Officer ('CFO') of the Company.

pdf

Kimia Biosciences Ltd.

04 Aug 2025

38.45

2.86%

Corp. Note

Kimia Biosciences Ltd - 530313 - Disclosure under Regulation 30A of LODR

BSE India

Disclosure under Regulation 30A of LODR-Clarification regarding inadvertent reference to SEBI in Warning letter communication .

pdf

Kimia Biosciences Ltd.

31 Jul 2025

38.45

2.86%

Corp. Note

Kimia Biosciences Ltd - 530313 - Disclosure under Regulation 30A of LODR

BSE India

Disclosure under Regulation 30A of SEBI (Listing Obligation and Disclosure Requirement)Regulations 2015

pdf

Kimia Biosciences Ltd.

24 Jul 2025, 07:12PM

38.45

2.86%

AGM

Kimia Biosciences Ltd - 530313 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

BSE India

DECLARATION OF RESULT OF REMOTE E-VOTING AND E-VOTING CONDUCTED DURING THE EXTRA-ORDINARY GENERAL MEETING HELD ON TUESDAY 22 JULY,2025 ALONG WITH THE SCRUTINISER REPORT UNDER REGULATION 44 OF SEBI(LISTING OBLIGATION AND DISCLOSURE REQUIREMENTS)REGULATIONS ,2015

pdf

Kimia Biosciences Ltd.

23 Jul 2025

38.45

2.86%

AGM

Kimia Biosciences Ltd - 530313 - Shareholder Meeting / Postal Ballot-Outcome of EGM

BSE India

DISCLOSURE UNDER REGULATION 30 OF SEBI (LISTING OBLIGATION AND DISCLOSURE REQUIREMENTS), REGULATIONS 2015("LISTING REGULATION ")READ WITH INDUSTRY STANDARDS ON LISTING REGULATION-SUMMARY OF PROCEEDINGS/OUTCOME OF THE EXTRA ORDINARY GENERAL MEETING OF THE COMPANY(EGM)

pdf

Is Kimia Biosciences Ltd. worth buying?

14 Votes:

Buy 71.43%

Sell 7.14%

Hold 21.43%